A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
for Inflammatory Bowel Diseases
25 locations incl. Lancaster
Sponsor: Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Sex: All·Age: 18 - 85
Code: NCT06226883·Phase 2·Recruiting·Listed Jan 2024